60 Degrees Pharmaceuticals, Inc. (SXTPW) stock

SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value

$0.03−0.00 (-0.38%)

Close on Oct 30, 2026Market cap $3.31MP/E –Yield –

60 Degrees Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

60 Degrees Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in 60 Degrees Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Jan 20, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SXTPW.

Revenue growth73.2% · median -52.3%

Operating margin-774.9% · median -1287.4%

Net margin-729.9% · median -1168.2%

Advertisement
300 × 250